Newly discovered hybrid molecules could serve as a novel category of anti-cancer agent

phys.org | 5/22/2019 | Staff
yana.booyana.boo (Posted by) Level 4
Click For Photo: https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2019/10-newlydiscove.jpg

Researchers from NYU Abu Dhabi's (NYUAD) chemistry program and colleagues from the University's biology program have developed and studied the biological activity of five new, metal-organic hybrid knotted molecules, termed metal-organic trefoil knots (M-TKs). These molecules can effectively deliver metals to cancer cells, demonstrating the potential to act as a new category of anti-cancer agents.

In a study published in the journal Chemical Science, NYUAD Research Scientists Farah Benyettou and Thirumurugan Prakasam from the Trabolsi Research Group, led by NYUAD Associate Professor of Chemistry Ali Trabolsi, report that these nanoscale, water-soluble M-TKs showed high potency in vitro against six cancer cell lines and in vivo in zebrafish embryos. Zebrafish-related studies were performed by NYUAD Postdoctoral Associate Anjana Ramdas Nair from the Sadler Lab.

M-TKs - Self-assembly - Pair - Ligands - Vitro

The M-TKs, generated by metal-templated self-assembly of a simple pair of chelating ligands, were well tolerated in vitro by non-cancer cells but were significantly more potent than cisplatin, a common chemotherapy medication, in both human cancer cells—including those that were cisplatin-resistant—and in zebrafish embryos. In cultured cells, M-TKs introduce reactive oxygen species (ROS) that damage the mitochondria of cancer cells, but not the nuclear DNA...
(Excerpt) Read more at: phys.org
Wake Up To Breaking News!
Government, where everything works great, until something has to work.
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!